EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood–Brain Barrier

Zih-An Chen, Cheng-Hsun Wu, Si-Han Wu iD, Chiung-Yin Huang, Chung-Yuan Mou iD, Kuo-Chen Wei, Yun Yen iD, I-Ting Chien, Sabiha Runa, Yi-Ping Chen iD, Peilin Chen iD

ACS Nano · 21.05.2024 · 18 (20) · 12716-12736

DOI: 10.1021/acsnano.3c08993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 08.05.2024. Verfasst von Zih-An Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Doxorubicin, Drug Carriers, Nanoparticles. Die Arbeit wurde bisher 129-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taipei Medical University, National Health Research Institutes, Academia Sinica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierDoxorubicinDrug CarriersNanoparticlesSilicon DioxideAnimalsHumansMiceAntibiotics, AntineoplasticBrain NeoplasmsCell Line, TumorGliomaLigandsParticle SizePolyethylene GlycolsPorosity

Stichwörter der Autor:innen

blood−brain barrierbrain tumordoxorubicinmesoporous silica nanoparticlesprotein coronathe enhanced permeability and retention effect

Substanzen

Antibiotics, AntineoplasticDoxorubicinDrug CarriersLigandsPolyethylene GlycolsSilicon Dioxide

Autor:innen und Institutionen

  • Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan.
  • Graduate Institute of Nanomedicine and Medical Engineering, Taipei Medical University, Taipei 11031, Taiwan.
  • Research Center for Applied Sciences, Academia Sinica, Taipei 11529, Taiwan.
  • Nano Targeting & Therapy Biopharma Inc., Taipei 10087, Taiwan.
  • International Ph.D. Program in Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan.
  • Neuroscience Research Center, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan.

ORCID-Profile: Si-Han Wu, Chung-Yuan Mou, Yun Yen, Yi-Ping Chen, Peilin Chen

Förderung

  • Taipei Medical University
  • National Health Research Institutes
  • Academia Sinica
  • Ministry of Science and Technology, Taiwan
  • National Science and Technology Council
  • Ministry of Education, Taiwan

Zitieren

APA

Chen, Z. A., Wu, C. H., Wu, S. H., Huang, C. Y., Mou, C. Y., Wei, K. C., Yen, Y., Chien, I. T., Runa, S., Chen, Y. P., & Chen, P. (2024). Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood–Brain Barrier. ACS Nano, 18(20), 12716-12736. https://doi.org/10.1021/acsnano.3c08993

Vancouver

Chen ZA, Wu CH, Wu SH, Huang CY, Mou CY, Wei KC, et al. Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood–Brain Barrier. ACS Nano. 2024;18(20):12716-12736. doi:10.1021/acsnano.3c08993

BibTeX
@article{Chen2024,
  author = {Chen, Zih-An and Wu, Cheng-Hsun and Wu, Si-Han and Huang, Chiung-Yin and Mou, Chung-Yuan and Wei, Kuo-Chen and Yen, Yun and Chien, I-Ting and Runa, Sabiha and Chen, Yi-Ping and Chen, Peilin},
  title = {Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood–Brain Barrier},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {20},
  pages = {12716--12736},
  doi = {10.1021/acsnano.3c08993}
}
Kostenlos starten →